Also trades as: BRM.V (TSXV) · $vol 0M
BIRMF OTC
BioRem Inc.
1W: +4.5%
1M: -11.5%
3M: +6.5%
YTD: +16.1%
1Y: +65.0%
3Y: +230.0%
5Y: +346.8%
$2.31
-0.08 (-3.23%)
Weekly Expected Move ±9.1%
$2
$2
$2
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$37M
+48.7% ▲
5Y CAGR: +12.6%
Gross Profit
$10M
+43.2% ▲
5Y CAGR: +15.6%
Operating Income
$4M
+41.8% ▲
Net Income
$3M
+39.7% ▲
EPS (Diluted)
$0.16
+23.1% ▲
EBITDA
$5M
+39.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $24M | $24M | $29M | $25M | $37M |
| YoY Growth | +18.0% | +0.4% | +17.9% | -12.8% | +48.7% |
| Cost of Revenue | $17M | $18M | $20M | $18M | $27M |
| Gross Profit | $7M | $6M | $9M | $7M | $10M |
| Gross Margin | 28.8% | 25.5% | 30.4% | 27.9% | 26.9% |
| R&D Expenses | $31K | $14K | $97K | $30K | $44K |
| SG&A Expenses | $5M | $4M | $6M | $4M | $6M |
| Operating Expenses | $4M | $4M | $6M | $4M | $6M |
| Operating Income | $3M | $2M | $3M | $3M | $4M |
| Operating Margin | 11.2% | 8.5% | 9.1% | 12.2% | 11.6% |
| Interest Expense | $44K | $36K | $257K | $273K | $195K |
| Income Before Tax | $3M | $2M | $2M | $3M | $4M |
| Tax Expense | $586K | $737K | $770K | $610K | $1M |
| Net Income | $2M | $1M | $2M | $2M | $3M |
| Net Margin | 8.6% | 5.3% | 5.6% | 8.7% | 8.1% |
| EPS (Diluted) | $0.05 | $0.03 | $0.09 | $0.13 | $0.16 |
| EBITDA | $3M | $3M | $3M | $3M | $5M |
| Shares Outstanding | 40M | 37M | 18M | 17M | 19M |